American BriVision Highlights Results from Vitargus First-in-Human Clinical Trial
Study results suggest Vitargus® is safe and well-tolerated and may be a viable vitreous substitute to be used…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Oct 19
Study results suggest Vitargus® is safe and well-tolerated and may be a viable vitreous substitute to be used…
16 Oct 19
Tobii Pro Fusion features stereoscopic system with two eye tracking cameras, which tolerates larger degrees of head movement
14 Oct 19
Topcon Harmony will provide seamless data migration from Merge and support all Eye Station users regardless of existing…
11 Oct 19
The use of artificial intelligence is enhancing the way retinal screenings can prevent blindness
11 Oct 19
The iStent infinite prospective, unmasked, multi-center, single-arm clinical trial enrolled subjects who had undergone prior unsuccessful incisional glaucoma…
11 Oct 19
With more than 90 variables and 14 FDA cleared tests, Neuro Kinetics is a major provider of eye-tracking…
10 Oct 19
OcuMedic has entered into an exclusive supply agreement and received a strategic investment from Gelest
10 Oct 19
This financing provides capital to fuel U.S. market growth, as well as to build a robust and sustainable…
10 Oct 19
QuickSee precisely measures patients' refractive error, the most common cause of vision impairment globally and often correctable with…
09 Oct 19
While both iStent and iStent inject showed significant IOP and medication reduction in combo-cataract procedures at 1 year…